In a cohort study where 849 patients were followed 1 year after a kidney transplant, 21.5% of them developed THPT, defined by elevated PTH levels (>70 pg/mL) and hypercalcemia (>10 mg/dL). The gene discussed is PTH; the disease is Hypercalcemia.